Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Comparison of Two Cancer Vaccines Targeting Tyrosinase: Plasmid DNA and Recombinant Alphavirus Replicon Particles

Clin Cancer Res (2005) 11 (22): 8114–8121.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Cancer vaccine strategies using self-replicating RNA viral platforms
  • Gabrielle P. Dailey
  • Erika J. Crosby
  • Zachary C. Hartman
Cancer Gene Therapy (2023) 30 (6): 794.
Alphavirus Replicon Particle Vaccine Breaks B Cell Tolerance and Rapidly Induces IgG to Murine Hematolymphoid Tumor Associated Antigens
  • Hsuan Su
  • Kazuhiro Imai
  • Wei Jia
  • Zhiguo Li
  • Rachel A. DiCioccio
  • Jonathan S. Serody
  • Jonathan C. Poe
  • Benny J. Chen
  • Phuong L. Doan
  • Stefanie Sarantopoulos
Frontiers in Immunology (2022) 13
Alphaviruses in Immunotherapy and Anticancer Therapy
  • Kenneth Lundstrom
Biomedicines (2022) 10 (9): 2263.
Mutated Shiitake extracts inhibit melanin-producing neural crest-derived cells in zebrafish embryo
  • Ibrahim Mahmood
  • Ahmad Azfaralariff
  • Azhar Mohamad
  • Othman B. Airianah
  • Douglas Law
  • Herryawan Ryadi Eziwar Dyari
  • Yi Chieh Lim
  • Shazrul Fazry
Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology (2021) 245: 109033.
Replicon RNA Viral Vectors as Vaccines
  • Kenneth Lundstrom
Vaccines (2016) 4 (4): 39.
Anti-tumor effect of the alphavirus-based virus-like particle vector expressing prostate-specific antigen in a HLA–DR transgenic mouse model of prostate cancer
  • V. Riabov
  • I. Tretyakova
  • R.B. Alexander
  • P. Pushko
  • E.N. Klyushnenkova
Vaccine (2015) 33 (41): 5386.
Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma
  • Kathrin Mählmann
  • Karsten Feige
  • Christiane Juhls
  • Anne Endmann
  • Hans-Joachim Schuberth
  • Detlef Oswald
  • Mareu Hellige
  • Marcus Doherr
  • Jessika-MV Cavalleri
BMC Veterinary Research (2015) 11 (1)
Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma
  • Kathrin Mählmann
  • Karsten Feige
  • Christiane Juhls
  • Anne Endmann
  • Hans-Joachim Schuberth
  • Detlef Oswald
  • Maren Hellige
  • Marcus Doherr
  • Jessika-MV Cavalleri
BMC Veterinary Research (2015) 11 (1)
Alphavirus-based vaccines in melanoma: rationale and potential improvements in immunotherapeutic combinations
  • Roberta Zappasodi
  • Taha Merghoub
Immunotherapy (2015) 7 (9): 981.
Combination of Alphavirus Replicon Particle–Based Vaccination with Immunomodulatory Antibodies: Therapeutic Activity in the B16 Melanoma Mouse Model and Immune Correlates
  • Francesca Avogadri
  • Roberta Zappasodi
  • Arvin Yang
  • Sadna Budhu
  • Nicole Malandro
  • Daniel Hirschhorn-Cymerman
  • Shakuntala Tiwari
  • Maureen F. Maughan
  • Robert Olmsted
  • Jedd D. Wolchok
  • Taha Merghoub
Cancer Immunology Research (2014) 2 (5): 448.
Xenogene vaccination in the therapy of cancer
  • Federica Cavallo
  • Luigi Aurisicchio
  • Rita Mancini
  • Gennaro Ciliberto
Expert Opinion on Biological Therapy (2014) 14 (10): 1427.
Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications
  • Xueling Yang
  • Zhi Guo
  • Ya Liu
  • Tongguo Si
  • Haipeng Yu
  • Bo Li
  • Wei Tian
Expert Review of Anticancer Therapy (2014) 14 (1): 31.
A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer
  • Susan F. Slovin
  • Marissa Kehoe
  • Robert Durso
  • Celina Fernandez
  • William Olson
  • Jian P. Gao
  • Robert Israel
  • Howard I. Scher
  • Stephen Morris
Vaccine (2013) 31 (6): 943.
Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
  • Jianda Yuan
  • Geoffrey Y Ku
  • Matthew Adamow
  • Zhenyu Mu
  • Sapna Tandon
  • Drew Hannaman
  • Paul Chapman
  • Gary Schwartz
  • Richard Carvajal
  • Katherine S Panageas
  • Alan N Houghton
  • Jedd D Wolchok
Journal for ImmunoTherapy of Cancer (2013) 1 (1): 20.
Early Treg suppression by a listeriolysin-O-expressing E. coli vaccine in heterologous prime–boost vaccination against cancer
  • Ming-Shen Dai
  • Georges Vassaux
  • Man Xu
  • Ren-In You
  • Yu-Feng Hsieh
  • Laure-Hélène Ouisse
  • Kai-Yu Lo
  • Huey-Kang Sytwu
  • Tsu-Yi Chao
Vaccine (2012) 30 (48): 6903.
New Perspectives on the Role of Vitiligo in Immune Responses to Melanoma
  • Katelyn T. Byrne
  • Mary Jo Turk
Oncotarget (2011) 2 (9): 684.
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer
  • Michael A. Morse
  • Amy C. Hobeika
  • Takuya Osada
  • Peter Berglund
  • Bolyn Hubby
  • Sarah Negri
  • Donna Niedzwiecki
  • Gayathri R. Devi
  • Bruce K. Burnett
  • Timothy M. Clay
  • Jonathan Smith
  • H. Kim Lyerly
Journal of Clinical Investigation (2010) 120 (9): 3234.
Role of T cell competition in the induction of cytotoxic T lymphocyte activity during viral vector-based immunization regimens
  • Annechien J.A. Lambeck
  • Hans W. Nijman
  • Baukje Nynke Hoogeboom
  • Joke Regts
  • Arjan de Mare
  • Jan Wilschut
  • Toos Daemen
Vaccine (2010) 28 (26): 4275.
Immunologic Response to Xenogeneic gp100 DNA in Melanoma Patients: Comparison of Particle-Mediated Epidermal Delivery with Intramuscular Injection
  • Brian A. Ginsberg
  • Humilidad F. Gallardo
  • Teresa S. Rasalan
  • Matthew Adamow
  • Zhenyu Mu
  • Sapna Tandon
  • Barrett B. Bewkes
  • Ruth-Ann Roman
  • Paul B. Chapman
  • Gary K. Schwartz
  • Richard D. Carvajal
  • Katherine S. Panageas
  • Stephanie L. Terzulli
  • Alan N. Houghton
  • Jianda D. Yuan
  • Jedd D. Wolchok
Clinical Cancer Research (2010) 16 (15): 4057.
Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity
  • Francesca Avogadri
  • Taha Merghoub
  • Maureen F. Maughan
  • Daniel Hirschhorn-Cymerman
  • John Morris
  • Erika Ritter
  • Robert Olmsted
  • Alan N. Houghton
  • Jedd D. Wolchok
  • Derya Unutmaz
PLoS ONE (2010) 5 (9): e12670.
DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells
  • Daejin Kim
  • Chien-Fu Hung
  • T.-C. Wu
  • Yeong-Min Park
Vaccine (2010) 28 (45): 7297.
Alphavirus vectors for cancer therapy
  • Jose I. Quetglas
  • Marta Ruiz-Guillen
  • Alejandro Aranda
  • Erkuden Casales
  • Jaione Bezunartea
  • Cristian Smerdou
Virus Research (2010) 153 (2): 179.
The Immunosuppressive Tumor Environment Is the Major Impediment to Successful Therapeutic Vaccination in Neu Transgenic Mice
  • Joseph E. Burgents
  • Timothy P. Moran
  • Michelle L. West
  • Nancy L. Davis
  • Robert E. Johnston
  • Jonathan S. Serody
Journal of Immunotherapy (2010) 33 (5): 482.
Novel strategies for improved cancer vaccines
  • Xiaochuan Chen
  • Chien-Hsing Chang
  • David M Goldenberg
Expert Review of Vaccines (2009) 8 (5): 567.
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers
  • David I. Bernstein
  • Elizabeth A. Reap
  • Kevin Katen
  • Aubrey Watson
  • Kaitlin Smith
  • Pamela Norberg
  • Robert A. Olmsted
  • Amy Hoeper
  • John Morris
  • Sarah Negri
  • Maureen F. Maughan
  • Jeffrey D. Chulay
Vaccine (2009) 28 (2): 484.
Xenogeneic immunization with human tyrosine hydroxylase DNA vaccines suppresses growth of established neuroblastoma
  • Nicole Huebener
  • Stefan Fest
  • Kerstin Hilt
  • Alexander Schramm
  • Angelika Eggert
  • Tahir Durmus
  • Anja Woehler
  • Alexander Stermann
  • Matthias Bleeke
  • Bianca Baykan
  • Silke Weixler
  • Gerhard Gaedicke
  • Holger N. Lode
Molecular Cancer Therapeutics (2009) 8 (8): 2392.
Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope
  • Yong Lu
  • Kedong Ouyang
  • Jing Fang
  • Huiyong Zhang
  • Guojun Wu
  • Yanjun Ma
  • Yu Zhang
  • Xiangbing Hu
  • Liang Jin
  • Rongyue Cao
  • Hao Fan
  • Taiming Li
  • Jingjing Liu
Vaccine (2009) 27 (39): 5411.
Prostate stem cell antigen: A prospective therapeutic and diagnostic target
  • Adam B. Raff
  • Andrew Gray
  • W. Martin Kast
Cancer Letters (2009) 277 (2): 126.
Phase I Trial of an Alhydrogel Adjuvanted Hepatitis B Core Virus-Like Particle Containing Epitopes of Plasmodium falciparum Circumsporozoite Protein
  • Aric L. Gregson
  • Giane Oliveira
  • Caroline Othoro
  • J. Mauricio Calvo-Calle
  • George B. Thorton
  • Elizabeth Nardin
  • Robert Edelman
  • Nicholas White
PLoS ONE (2008) 3 (2): e1556.
Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity
  • Maria de la Luz Garcia-Hernandez
  • Andrew Gray
  • Bolyn Hubby
  • Otto J. Klinger
  • W. Martin Kast
Cancer Research (2008) 68 (3): 861.
Adjuvant potential of aggregate-forming polyglutamine domains
  • P.O. Ilyinskii
  • G. Thoidis
  • M.Y. Sherman
  • A. Shneider
Vaccine (2008) 26 (26): 3223.
Delivery strategies of melanoma vaccines: an overview
  • Yin Hwa Lai
  • Chong Wang
Expert Opinion on Drug Delivery (2008) 5 (9): 979.
Phase I/II Study of GM-CSF DNA as an Adjuvant for a Multipeptide Cancer Vaccine in Patients With Advanced Melanoma
  • Miguel-Angel Perales
  • Jianda Yuan
  • Sarah Powel
  • Humilidad F Gallardo
  • Teresa S Rasalan
  • Christina Gonzalez
  • Gregor Manukian
  • Jian Wang
  • Yan Zhang
  • Paul B Chapman
  • Susan E Krown
  • Philip O Livingston
  • Samuel Ejadi
  • Katherine S Panageas
  • Manuel E Engelhorn
  • Stephanie L Terzulli
  • Alan N Houghton
  • Jedd D Wolchok
Molecular Therapy (2008) 16 (12): 2022.
Comparative Prime-Boost Vaccinations Using Semliki Forest Virus, Adenovirus, and ALVAC Vectors Demonstrate Differences in the Generation of a Protective Central Memory CTL Response against the P815 Tumor
  • Tanja I. Näslund
  • Catherine Uyttenhove
  • Eva K. L. Nordström
  • Didier Colau
  • Guy Warnier
  • Mikael Jondal
  • Benoı̂t J. Van den Eynde
  • Peter Liljeström
The Journal of Immunology (2007) 178 (11): 6761.
Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine
  • Karl Ljungberg
  • Alan C. Whitmore
  • Meagan E. Fluet
  • Timothy P. Moran
  • Reed S. Shabman
  • Martha L. Collier
  • Annette A. Kraus
  • Joseph M. Thompson
  • David C. Montefiori
  • Clayton Beard
  • Robert E. Johnston
Journal of Virology (2007) 81 (24): 13412.
Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics
  • Yifat Merbl
  • Merav Zucker-Toledano
  • Francisco J. Quintana
  • Irun R. Cohen
Journal of Clinical Investigation (2007) 117 (3): 712.
A Novel Alphavirus Vaccine Encoding Prostate-Specific Membrane Antigen Elicits Potent Cellular and Humoral Immune Responses
  • Robert J. Durso
  • Sofija Andjelic
  • Jason P. Gardner
  • Dennis J. Margitich
  • Gerald P. Donovan
  • Robert R. Arrigale
  • Xinning Wang
  • Maureen F. Maughan
  • Todd L. Talarico
  • Robert A. Olmsted
  • Warren D.W. Heston
  • Paul J. Maddon
  • William C. Olson
Clinical Cancer Research (2007) 13 (13): 3999.
Safety and Immunogenicity of Tyrosinase DNA Vaccines in Patients with Melanoma
  • Jedd D Wolchok
  • Jianda Yuan
  • Alan N Houghton
  • Humilidad F Gallardo
  • Teresa S Rasalan
  • Jian Wang
  • Yan Zhang
  • Rajaram Ranganathan
  • Paul B Chapman
  • Susan E Krown
  • Philip O Livingston
  • Melanie Heywood
  • Isabelle Riviere
  • Katherine S Panageas
  • Stephanie L Terzulli
  • Miguel A Perales
Molecular Therapy (2007) 15 (11): 2044.
Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D
  • Jacek Kowalski
  • Karissa Adkins
  • Seema Gangolli
  • Jian Ren
  • Heather Arendt
  • Joanne DeStefano
  • Jennifer Obregon
  • Donna Tummolo
  • Robert J. Natuk
  • Tom P. Brown
  • Christopher L. Parks
  • Stephen A. Udem
  • Deborah Long
Vaccine (2007) 25 (12): 2296.
VRP immunotherapy targeting neu: treatment efficacy and evidence for immunoediting in a stringent rat mammary tumor model
  • Amanda K. Laust
  • Brandon W. Sur
  • Kehui Wang
  • Bolyn Hubby
  • Jonathan F. Smith
  • Edward L. Nelson
Breast Cancer Research and Treatment (2007) 106 (3): 371.
  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept